![Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism | SpringerLink Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40263-015-0278-3/MediaObjects/40263_2015_278_Fig1_HTML.gif)
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism | SpringerLink
![PDF) Mechanism of Action of Aripiprazole Predicts Clinical Efficacy and a Favourable Side-Effect Profile PDF) Mechanism of Action of Aripiprazole Predicts Clinical Efficacy and a Favourable Side-Effect Profile](https://i1.rgstatic.net/publication/8355210_Mechanism_of_Action_of_Aripiprazole_Predicts_Clinical_Efficacy_and_a_Favourable_Side-Effect_Profile/links/55424efb0cf234bdb21a0faa/largepreview.png)
PDF) Mechanism of Action of Aripiprazole Predicts Clinical Efficacy and a Favourable Side-Effect Profile
![Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole - Kikuchi - 2021 - Neuropsychopharmacology Reports - Wiley Online Library Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole - Kikuchi - 2021 - Neuropsychopharmacology Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/283cc1b7-4e4c-40ad-870d-bdfa77e2d737/npr212180-toc-0001-m.jpg)
Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole - Kikuchi - 2021 - Neuropsychopharmacology Reports - Wiley Online Library
![Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents | Molecular Psychiatry Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents | Molecular Psychiatry](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmp.2012.47/MediaObjects/41380_2012_Article_BFmp201247_Fig1_HTML.jpg)
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents | Molecular Psychiatry
![Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole - Kikuchi - 2021 - Neuropsychopharmacology Reports - Wiley Online Library Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole - Kikuchi - 2021 - Neuropsychopharmacology Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/84496dbd-659d-418c-b518-f7f783b72f69/npr212180-fig-0003-m.jpg)